Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: CENPF/CDK1 signaling pathway enhances the progression of adrenocortical carcinoma by regulating the G2/M-phase cell cycle

Fig. 3

Prognosis analysis of CENPF in clinicopathological parameters for ACC patients. a CENPF expression (high or low) and survival status (alive or dead) of ACC patients. All the sample order is consistent. b Sanguini diagram for depicting the distribution of CENPF expression in age, gender, pTNM stage, and survival status. The P-value and hazard ratio of CENPF and associated parameters of the uni-cox (c) and multi-cox (d) analysis. e Nomogram for assessing the survival rate of 1-year, 2- year, and 3-year in ACC patients related to CENPF expression

Back to article page